⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for French Registry of First-line Treatment of Acute Promyelocytic Leukemia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: French Registry of First-line Treatment of Acute Promyelocytic Leukemia

Official Title: The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years

Study ID: NCT02938858

Interventions

Study Description

Brief Summary: The registry aims to compare the two first-line available treatment approaches in non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO - in terms of practitioner's choice between the two options, clinical effectiveness and cost-effectiveness, long-term outcome, and short- and long-term toxic effects.

Detailed Description: * Collection of epidemiological data on non-high-risk APL patients aged ≤ 70 years: age and sex distribution, medical history, prognostic factors (time to treatment start, severity of coagulopathy at presentation, Performance status...). * Documentation of clinical and biologic effectiveness of the two first-line treatment approaches available for non-high-risk APL patients. * Documentation of Minimal Residual Disease (MRD). * Correlation of clinical outcomes with the chosen therapy. * Validation of published prognostic factors and identification of new prognostic factors

Keywords

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Centre Hospitalier d'Aix en Provence, Aix en Provence, , France

Groupe Hospitalier SUD, Amiens, , France

Centre Hospitalier V. Dupouy, Argenteuil, , France

Hôpital Jean Minjoz, Besançon, , France

CHU Bordeaux Pellegrin enfant, Bordeaux, , France

CHRU de Brest - Pédiatrie Spécialisée, Brest, , France

CHU Estaing, Clermont-Ferrand, , France

Hôpital Henri Mondor, Créteil, , France

CHU de Grenoble, Grenoble, , France

Hopital Andre Mignot, Le Chesnay, , France

CH Dr Schaffner, Lens, , France

Chru - Hopital Claude Huriez, Lille, , France

Hôpital universitaire Dupuytren, Limoges, , France

Institut Paoli Calmettes, Marseille, , France

Chu Timone, Marseille, , France

CHR Metz-Thionville - Hôpital de Marcy, Metz, , France

CHU Saint Eloi, Montpellier, , France

CHU Hôtel Dieu, Nantes, , France

Hôpital de la Source, Orléans, , France

Hôpital TROUSSEAU, Paris, , France

Hôpital Necker, Paris, , France

Hôpital Robert Debré, Paris, , France

CHU Hôpital Sud - service Hémato-oncologie Pédiatrique, Rennes, , France

Hôpital V. Provo, Roubaix, , France

Centre Henri Becquerel, Rouen, , France

Institut de Cancerologie de La Loire, Saint Priest-en-jarez, , France

IUCT Oncopole, Toulouse, , France

Contact Details

Name: Pierre FENAUX, MD

Affiliation: French APL Cooperative Group

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: